Abstracts

VALIDATION OF A GENOTYPE-INDEPENDENT HEPATITIS C WHOLE-GENOME SEQUENCING ASSAY

Recent development of direct-acting antiviral agents (DAA) has dramatically improved the effectiveness and tolerability of treatments for hepatitis C virus (HCV), resulting in >95% sustained virologic response (SVR) rates. However, cases of treatment failure have been associated with the emergence of resistance-associated substitutions (RAS). To better guide clinical decision-making, we developed and validated a near-whole-genome,…

EPIDEMIC HISTORY OF HEPATITIS C VIRUS AMONG MSM IN AMSTERDAM, THE NETHERLANDS

To strengthen HCV micro-elimination efforts in the MSM community, a better understanding of transmission networks is vital. Insight in the proportion of new HCV infections that results from ongoing transmission of local variants versus new infections via external introductions may further guide specific local elimination efforts. We describe the epidemic history of HCV infections among…

HCV ANTIBODY AVIDITY–BASED METHOD TO ESTIMATE POPULATION-LEVEL INCIDENCE

Accurate hepatitis C virus (HCV) incidence estimates are critical for monitoring progress towards hepatitis C elimination goals which include a reduction in HCV incidence of 80% by 2030. Moreover, incidence estimates can help guide local prevention and treatment programming, particularly in the context of the US opioid epidemic. An inexpensive ($4/sample), Genedia-based HCV IgG antibody…

HIGH KYNURENINE:TRYPTOPHAN RATIO IS ASSOCIATED WITH LIVER FIBROSIS IN HIV INFECTION

The kynurenine:tryptophan ratio (KTR), a marker of tryptophan catabolism, is associated with impaired T-cell function. Higher KTR has been associated with increased mortality, cardiovascular disease, and neurologic conditions in HIV+ persons. Its role in liver fibrosis is unknown. We examined the association of KTR with liver fibrosis in women with and without HIV infection. Serum…

MORTALITY AFTER DIALYSIS INITIATION AMONG PATIENTS WITH CHRONIC HEPATITIS C INFECTION

End-stage renal disease (ESRD) is an important extrahepatic manifestation among chronic hepatitis C virus (HCV)-infected individuals. However, there is little information on survival in these patients after initiating dialysis. Our objective was to investigate all-cause mortality among HCV-infected dialysis patients and whether survival differs with HIV and/or hepatitis B virus (HBV) coinfection or HCV treatment.…

SYNDEMIC HIV AND HEPATITIS VIRAL COINFECTIONS AND INCIDENT END-STAGE RENAL DISEASE

Syndemic viral coinfections, including hepatitis B virus (HBV), hepatitis C virus (HCV) and/or HIV have been associated with premature mortality, however there is little data on their impact on chronic comorbidities, including end-stage renal disease (ESRD). We evaluated the association between coinfections and incident ESRD, independent of traditional risk factors. The British Columbia Hepatitis Testers…